EOS884448
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EOS884448, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: First-In-Human Study of EOS884448 in Participants with Advanced Cancers. [Phase 1]